Annual CFF
-$80.00 K
-$28.76 M-100.28%
31 December 2023
Summary:
NeuroBo Pharmaceuticals annual cash flow from financing activities is currently -$80.00 thousand, with the most recent change of -$28.76 million (-100.28%) on 31 December 2023. During the last 3 years, it has fallen by -$22.11 million (-100.36%). NRBO annual CFF is now -100.25% below its all-time high of $31.46 million, reached on 31 December 2016.NRBO Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$676.00 K
-$19.88 M-103.52%
30 September 2024
Summary:
NeuroBo Pharmaceuticals quarterly cash flow from financing activities is currently -$676.00 thousand, with the most recent change of -$19.88 million (-103.52%) on 30 September 2024. Over the past year, it has dropped by -$676.00 thousand (-100.00%). NRBO quarterly CFF is now -102.35% below its all-time high of $28.82 million, reached on 31 December 2022.NRBO Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$18.52 M
-$676.00 K-3.52%
30 September 2024
Summary:
NeuroBo Pharmaceuticals TTM cash flow from financing activities is currently $18.52 million, with the most recent change of -$676.00 thousand (-3.52%) on 30 September 2024. Over the past year, it has increased by +$18.60 million (+23255.00%). NRBO TTM CFF is now -56.78% below its all-time high of $42.86 million, reached on 31 March 2017.NRBO TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NRBO Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -100.0% | +10000.0% |
| 3 y3 years | -100.4% | -105.3% | -15.9% |
| 5 y5 years | -100.3% | -10000.0% | -23.4% |
NRBO Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -100.3% | at low | -102.3% | at low | -35.5% | >+9999.0% |
| 5 y | 5 years | -100.3% | at low | -102.3% | at low | -35.5% | >+9999.0% |
| alltime | all time | -100.3% | at low | -102.3% | +88.5% | -56.8% | +409.9% |
NeuroBo Pharmaceuticals Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$676.00 K(-103.5%) | $18.52 M(-3.5%) |
| June 2024 | - | $19.20 M(>+9900.0%) | $19.20 M(<-9900.0%) |
| Mar 2024 | - | $0.00(0.0%) | -$80.00 K(0.0%) |
| Dec 2023 | -$80.00 K(-100.3%) | $0.00(0.0%) | -$80.00 K(-100.3%) |
| Sept 2023 | - | $0.00(-100.0%) | $28.73 M(+0.5%) |
| June 2023 | - | -$80.00 K(<-9900.0%) | $28.60 M(-0.3%) |
| Mar 2023 | - | $0.00(-100.0%) | $28.68 M(0.0%) |
| Dec 2022 | $28.68 M(+30.2%) | $28.82 M(<-9900.0%) | $28.68 M(+124.9%) |
| Sept 2022 | - | -$134.00 K(<-9900.0%) | $12.75 M(-0.9%) |
| June 2022 | - | $0.00(0.0%) | $12.86 M(-0.6%) |
| Mar 2022 | - | $0.00(-100.0%) | $12.93 M(-41.3%) |
| Dec 2021 | $22.03 M(+221.2%) | $12.89 M(<-9900.0%) | $22.03 M(+141.0%) |
| Sept 2021 | - | -$24.00 K(-133.3%) | $9.14 M(-0.3%) |
| June 2021 | - | $72.00 K(-99.2%) | $9.16 M(-42.4%) |
| Mar 2021 | - | $9.09 M(>+9900.0%) | $15.90 M(+131.8%) |
| Dec 2020 | $6.86 M(-71.6%) | $0.00(0.0%) | $6.86 M(-0.0%) |
| Sept 2020 | - | $0.00(-100.0%) | $6.86 M(+0.1%) |
| June 2020 | - | $6.80 M(>+9900.0%) | $6.85 M(-71.7%) |
| Mar 2020 | - | $53.00 K(+5200.0%) | $24.22 M(+0.2%) |
| Dec 2019 | $24.17 M | $1000.00(-111.1%) | $24.17 M(+32.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2019 | - | -$9000.00(-100.0%) | $18.28 M(-0.3%) |
| June 2019 | - | $24.18 M(>+9900.0%) | $18.34 M(-406.8%) |
| Mar 2019 | - | $0.00(-100.0%) | -$5.98 M(-134.7%) |
| Dec 2018 | $17.25 M(-19.2%) | -$5.88 M(<-9900.0%) | $17.25 M(-25.1%) |
| Sept 2018 | - | $51.00 K(-135.4%) | $23.02 M(-30.5%) |
| June 2018 | - | -$144.00 K(-100.6%) | $33.12 M(+0.1%) |
| Mar 2018 | - | $23.22 M(<-9900.0%) | $33.09 M(+55.1%) |
| Dec 2017 | $21.34 M(-32.2%) | -$107.00 K(-101.1%) | $21.34 M(+2.9%) |
| Sept 2017 | - | $10.15 M(-6000.0%) | $20.73 M(-45.1%) |
| June 2017 | - | -$172.00 K(-101.5%) | $37.76 M(-11.9%) |
| Mar 2017 | - | $11.47 M(-1709.0%) | $42.86 M(+36.3%) |
| Dec 2016 | $31.46 M(+260.1%) | -$713.00 K(-102.6%) | $31.46 M(-9.3%) |
| Sept 2016 | - | $27.18 M(+451.6%) | $34.69 M(+238.8%) |
| June 2016 | - | $4.93 M(+7480.0%) | $10.24 M(+57.7%) |
| Mar 2016 | - | $65.00 K(-97.4%) | $6.49 M(-25.7%) |
| Dec 2015 | $8.74 M(+1616.3%) | $2.52 M(-7.3%) | $8.74 M(+40.7%) |
| Sept 2015 | - | $2.72 M(+130.8%) | $6.21 M(+78.1%) |
| June 2015 | - | $1.18 M(-48.9%) | $3.49 M(+51.1%) |
| Mar 2015 | - | $2.31 M | $2.31 M |
| Dec 2014 | $509.00 K | - | - |
FAQ
- What is NeuroBo Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for NeuroBo Pharmaceuticals?
- What is NeuroBo Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for NeuroBo Pharmaceuticals?
- What is NeuroBo Pharmaceuticals quarterly CFF year-on-year change?
- What is NeuroBo Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for NeuroBo Pharmaceuticals?
- What is NeuroBo Pharmaceuticals TTM CFF year-on-year change?
What is NeuroBo Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of NRBO is -$80.00 K
What is the all time high annual CFF for NeuroBo Pharmaceuticals?
NeuroBo Pharmaceuticals all-time high annual cash flow from financing activities is $31.46 M
What is NeuroBo Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of NRBO is -$676.00 K
What is the all time high quarterly CFF for NeuroBo Pharmaceuticals?
NeuroBo Pharmaceuticals all-time high quarterly cash flow from financing activities is $28.82 M
What is NeuroBo Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, NRBO quarterly cash flow from financing activities has changed by -$676.00 K (-100.00%)
What is NeuroBo Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of NRBO is $18.52 M
What is the all time high TTM CFF for NeuroBo Pharmaceuticals?
NeuroBo Pharmaceuticals all-time high TTM cash flow from financing activities is $42.86 M
What is NeuroBo Pharmaceuticals TTM CFF year-on-year change?
Over the past year, NRBO TTM cash flow from financing activities has changed by +$18.60 M (+23255.00%)